Gyon Technologies Capital Management, LP Incyte Corp Transaction History

Gyon Technologies Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$66.18 - $82.86 $284,838 - $356,629	4,304 New	4,304 $287,000
Q2 2021 Aug 16, 2021	SELL	$79.87 - $87.53 $943,104 - $1.03 Million	-11,808 Reduced 56.11%	9,235 $777,000
Q1 2021 May 17, 2021	SELL	$76.02 - $100.5 $859,710 - $1.14 Million	-11,309 Reduced 34.96%	21,043 $1.71 Million
Q4 2020 Feb 16, 2021	BUY	$80.74 - $97.7 $2.04 Million - $2.47 Million	25,285 Added 357.79%	32,352 $2.81 Million
Q3 2020 Nov 16, 2020	BUY	$85.07 - $109.69 $601,189 - $775,179	7,067 New	7,067 $634,000

644

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Gyon Technologies Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Gyon Technologies Capital Management, LP with notifications on news.